MyoKardia (MYOK)

48.35 +0.30 (0.62%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (5/7/18 *Est.)

Latest Headlines

Form 8-K MyoKardia Inc For: Jun 12 June 15, 2018 4:09 PM - SEC Filing Form 4 MyoKardia Inc For: Jun 12 Filed by: Meeker David P June 14, 2018 4:10 PM - SEC Filing Form 4 MyoKardia Inc For: Jun 12 Filed by: CRANSTON MARY B June 14, 2018 4:10 PM - SEC Filing Form 4 MyoKardia Inc For: Jun 12 Filed by: AGARWAL SUNIL June 14, 2018 4:09 PM - SEC Filing Form 4 MyoKardia Inc For: Jun 12 Filed by: Popovits Kimberly J June 14, 2018 4:09 PM - SEC Filing Form 4 MyoKardia Inc For: Jun 12 Filed by: PERRY MARK L June 14, 2018 4:08 PM - SEC Filing Form 4 MyoKardia Inc For: Jun 12 Filed by: YARNO WENDY L June 14, 2018 4:07 PM - SEC Filing Form 4 MyoKardia Inc For: Jun 04 Filed by: GIANAKAKOS ANASTASIOS June 6, 2018 7:35 PM - SEC Filing Form 4 MyoKardia Inc For: Apr 30 Filed by: Lee June June 1, 2018 4:26 PM - SEC Filing Form 4 MyoKardia Inc For: Apr 30 Filed by: Lambing Joseph June 1, 2018 4:26 PM - SEC Filing Form 4 MyoKardia Inc For: May 25 Filed by: Sanofi May 29, 2018 4:37 PM - SEC Filing Form 8-K MyoKardia Inc For: May 22 May 23, 2018 5:14 PM - SEC Filing Form 424B5 MyoKardia Inc May 23, 2018 5:04 PM - SEC Filing MyoKardia (MYOK) Prices 3.75M Share Common Offering at $49/Sh May 23, 2018 5:40 AM - StreetInsider MyoKardia Announces Pricing of Public Offering of Common Stock May 22, 2018 8:05 PM - Globe NewsWire Form 424B5 MyoKardia Inc May 21, 2018 5:30 PM - SEC Filing MyoKardia (MYOK) Announces Proposed 3.75M Share Common Offering May 21, 2018 4:02 PM - StreetInsider MyoKardia Announces Proposed Public Offering of Common Stock May 21, 2018 4:01 PM - Globe NewsWire Form 8-K MyoKardia Inc For: May 21 May 21, 2018 7:46 AM - SEC Filing MyoKardia (MYOK) Announces Design of Phase 3 EXPLORER-HCM Study Evaluating Mavacamten in oHCM May 21, 2018 7:34 AM - StreetInsider MyoKardia Announces Design of Phase 3 EXPLORER-HCM Study Evaluating Mavacamten in Symptomatic, Obstructive Hypertrophic Cardiomyopathy May 21, 2018 7:30 AM - Globe NewsWire MyoKardia to Present at the Bank of America Merrill Lynch 2018 Health Care Conference May 10, 2018 4:30 PM - Globe NewsWire MyoKardia (MYOK) Doses First Patient in PIONEER Open-Label Extension Study of Mavacamten May 10, 2018 8:35 AM - StreetInsider MyoKardia Doses First Patient in PIONEER Open-Label Extension Study of Mavacamten for Symptomatic, Obstructive Hypertrophic Cardiomyopathy May 10, 2018 8:30 AM - Globe NewsWire Form 10-Q MyoKardia Inc For: Mar 31 May 8, 2018 4:53 PM - SEC Filing Form 8-K MyoKardia Inc For: May 08 May 8, 2018 4:23 PM - SEC Filing MyoKardia Reports First Quarter 2018 Financial Results May 8, 2018 4:01 PM - Globe NewsWire Form SC 13G/A MyoKardia Inc Filed by: BlackRock Inc. May 8, 2018 11:51 AM - SEC Filing Form 4 MyoKardia Inc For: May 04 Filed by: GIANAKAKOS ANASTASIOS May 7, 2018 9:49 PM - SEC Filing Form 4 MyoKardia Inc For: May 03 Filed by: Bauer Jake May 7, 2018 5:44 PM - SEC Filing MyoKardia to Report First Quarter 2018 Financial Results on Tuesday, May 8, 2018 May 3, 2018 4:01 PM - Globe NewsWire Form DEF 14A MyoKardia Inc For: Jun 12 April 17, 2018 6:08 AM - SEC Filing Form DEFA14A MyoKardia Inc April 17, 2018 6:07 AM - SEC Filing MyoKardia (MYOK) PT Raised to $70 at Wells Fargo April 13, 2018 7:47 AM - StreetInsider Form 4 MyoKardia Inc For: Apr 11 Filed by: Bauer Jake April 12, 2018 8:33 PM - SEC Filing Form 4 MyoKardia Inc For: Apr 04 Filed by: GIANAKAKOS ANASTASIOS April 5, 2018 7:50 PM - SEC Filing Form 4 MyoKardia Inc For: Apr 04 Filed by: Harris Taylor C. April 5, 2018 7:40 PM - SEC Filing Form 3 MyoKardia Inc For: Apr 04 Filed by: Harris Taylor C. April 5, 2018 7:37 PM - SEC Filing Form 8-K MyoKardia Inc For: Apr 04 April 4, 2018 9:27 AM - SEC Filing MyoKardia (MYOK) Names Taylor C. Harris as Chief Financial Officer April 4, 2018 8:35 AM - StreetInsider MyoKardia Announces Appointment of Taylor C. Harris as Chief Financial Officer April 4, 2018 8:30 AM - Globe NewsWire MyoKardia (MYOK) Commences Dosing in Phase 2 MAVERICK-HCM Clinical Trial of Mavacamten April 2, 2018 8:35 AM - StreetInsider MyoKardia Begins Dosing in Phase 2 MAVERICK-HCM Clinical Trial of Mavacamten in Symptomatic Non-obstructive Hypertrophic Cardiomyopathy Patients April 2, 2018 8:30 AM - Globe NewsWire Form 4 MyoKardia Inc For: Mar 26 Filed by: Bauer Jake March 28, 2018 4:10 PM - SEC Filing Full Article List